drugset / Trial / NCT06487585
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
Phase 4
Recruiting
100 enrolled
University of Maryland St. Joseph Medical Center
La Jolla Pharmaceutical Company · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.
Timeline
- Start
- 2025-05-06
- Primary completion
- 2026-01
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Angiotensin II | Peptide | 2.5 unknown | Intravenous |